EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSBBBG00000011704
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSBBBG00000011702
Gene Symbol: TLR8
3 Cross references
199 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSBBBG00000003495
Gene Symbol: TLR9
3 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSBBBG00000023129
Gene Symbol: TAAR1
3 Cross references
600 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSBBBG00000019241
Gene Symbol: TGFBR1
3 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSBBBG00000020321
Gene Symbol: TRPA1
3 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSBBBG00000022370
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSBBBG00000008033
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Transthyretin

Ensembl ID : ENSBBBG00000019495
Gene Symbol: TTR
3 Cross references
165 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSBBBG00000007903
Gene Symbol: TPH1
3 Cross references
257 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSBBBG00000007243
Gene Symbol: TUBA1A
3 Cross references
76 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSBBBG00000023348
Gene Symbol: TUBA1B
3 Cross references
92 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).